A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation
Yoshiyasu Aizawa, Tomohiro Matsuhashi, Toshiaki Sato, Seiji Takatsuki, Keiichi FukudaDivision of Cardiology, Keio University School of Medicine, Tokyo, JapanAbstract: Rhythm control therapy by sodium channel blockers is widely performed for the ­treatment of paroxysmal atrial fibrillatio...
Main Authors: | Yoshiyasu Aizawa, Tomohiro Matsuhashi, Toshiaki Sato, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-08-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/a-danger-of-induction-of-brugada-syndrome-during-pill-in-the-pocket-th-a5115 |
Similar Items
-
“Pill in the pocket” strategy for atrial fibrillation treatment
by: B. A. Tatarsky
Published: (2005-08-01) -
Long‐Term Outcomes of Pulmonary Vein Isolation in Patients With Brugada Syndrome and Paroxysmal Atrial Fibrillation
by: Antonio Bisignani, et al.
Published: (2022-08-01) -
“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
by: Linling Li, et al.
Published: (2019-03-01) -
Systematic review and cost-effectiveness evaluation of ‘pill-in-the-pocket’ strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy
by: C Martin Saborido, et al.
Published: (2010-06-01) -
Successful Catheter Ablation for Paroxysmal Atrial Fibrillation Originating from Superior Vena Cava in a Patient with Brugada Syndrome
by: Toshiya Kurotobi, MD PHD, et al.
Published: (2005-01-01)